Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 822 of 1,261
  1. US 8697076

    Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies

    Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  2. US 8697046

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  3. US 8697060

    Treatment method for relapsing-remitting multiple sclerosis

    REGENEX LLC · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  4. US 8695119

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  5. US 8697034

    Hyperpolarized 89-yttrium and methods relating thereto

    The Board of Regents of the University of Texas System · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  6. US 8697744

    Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  7. US 8697138

    Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

    Aker Biomarine AS · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  8. US 8691778

    Flurbiprofen and muscle relaxant gel combinations thereof

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  9. US 8691768

    Methods of determining delta opioid receptor subtypes

    The Regents of the University of California · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  10. US 8691511

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  11. US 8691522

    Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof

    Aeon Medix Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  12. US 8691501

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  13. US 8691195

    Peptide having activity of transforming growth factor and production method therefor

    CAREGEN CO., LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  14. US 8691204

    Synthetic diblock copolypeptide hydrogels for use in the central nervous system

    The Regents of the University of California · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  15. US 8691963

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  16. US 8691831

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  17. US 8692052

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  18. US 8691943

    Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  19. US 8691872

    Dispersions of rasagiline citrate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  20. US 8691967

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Benitec, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  21. US 8692051

    Methods for testing for caloric restriction (CR) mimetics

    BioMarker Pharmaceuticals, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  22. US 8691828

    Thienopyrimidine as CDC7 kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  23. US 8691849

    3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  24. US 8691796

    Pharmaceutical composition and method for inhibiting inflammation

    China Medical University · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.